Hyun Kyoung Lee

Title: Hyun Kyoung Lee: Innovator in Bioinformatics

Introduction

Hyun Kyoung Lee is a prominent inventor based in Daejeon, South Korea. She has made significant contributions to the field of bioinformatics, particularly in the identification and quantification of glycopeptides. With a total of 2 patents, her work is paving the way for advancements in disease diagnosis and therapeutic development.

Latest Patents

Hyun Kyoung Lee's latest patents include a bioinformatics platform for high-throughput identification and quantification of O-glycopeptides. This invention relates to a bioinformation processing analysis method that utilizes high-resolution mass spectrometry for the efficient and accurate analysis of O-linked glycopeptides. The method allows for the prediction or diagnosis of diseases, including cancer, and facilitates the investigation of therapeutic glycoprotein structures.

Another notable patent is her bioinformatics platform for high-throughput identification and quantification of N-glycopeptides. This invention provides a more efficient and accurate method for identifying and quantifying low-abundant glycopeptides compared to general peptides. The technique is particularly useful for identifying biotherapeutics and screening glycopeptide disease markers from various samples.

Career Highlights

Hyun Kyoung Lee is affiliated with the Korea Basic Science Institute, where she continues to advance her research in bioinformatics. Her innovative approaches have garnered attention in the scientific community, contributing to the understanding of glycopeptides and their implications in health and disease.

Collaborations

Hyun Kyoung Lee collaborates with notable colleagues, including Gun Wook Park and Jong Shin Yoo. These partnerships enhance her research capabilities and foster a collaborative environment for innovation.

Conclusion

Hyun Kyoung Lee's contributions to bioinformatics and her innovative patents are instrumental in advancing the field of glycopeptide research. Her work not only aids in disease diagnosis but also enhances the understanding of therapeutic glycoproteins.